Recent Advances in Drosophila Models of Charcot-Marie-Tooth Disease

International Journal of Molecular Sciences

Fukiko Kitani-Morii¹  Yu-ichi Noto² 

[1] Department of Molecular Pathobiology of Brain Disease, Kyoto Prefectural University of Medicine, Kyoto 6028566, Japan;Department of Neurology, Kyoto Prefectural University of Medicine, Kyoto 6028566, Japan;

关键词: Charcot-Marie-Tooth disease (CMT);    Drosophila melanogaster;    human disease model;    neurodegeneration;    peripheral neuropathy;   

DOI  :  10.3390/ijms21197419

来源: DOAJ

【 摘 要 】

Charcot-Marie-Tooth disease (CMT) is one of the most common inherited peripheral neuropathies. CMT patients typically show slowly progressive muscle weakness and sensory loss in a distal dominant pattern in childhood. The diagnosis of CMT is based on clinical symptoms, electrophysiological examinations, and genetic testing. Advances in genetic testing technology have revealed the genetic heterogeneity of CMT; more than 100 genes containing the disease causative mutations have been identified. Because a single genetic alteration in CMT leads to progressive neurodegeneration, studies of CMT patients and their respective models revealed the genotype-phenotype relationships of targeted genes. Conventionally, rodents and cell lines have often been used to study the pathogenesis of CMT. Recently, Drosophila has also attracted attention as a CMT model. In this review, we outline the clinical characteristics of CMT, describe the advantages and disadvantages of using Drosophila in CMT studies, and introduce recent advances in CMT research that successfully applied the use of Drosophila, in areas such as molecules associated with mitochondria, endosomes/lysosomes, transfer RNA, axonal transport, and glucose metabolism.

【 授权许可】

Unknown